Sébastien Déglise
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sébastien Déglise has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
- Florent Allagnat
Department of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland
10 shared publications - François Saucy
Service of Vascular Surgery, Ensemble Hospitalier de la Côte, Morges, Switzerland
7 shared publications Jean-Marc Corpataux
Department of Vascular Surgery, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
7 shared publications- Alban Longchamp
Transplant Center, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA
6 shared publications - Martine Lambelet
Department of Vascular Surgery, Lausanne University Hospital (CHUV), 1005 Lausanne, Switzerland
5 shared publications Céline Deslarzes-Dubuis
Department of Vascular Surgery, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
4 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in SSRN Electronic Journal
Short-term carbohydrate supplementation induces protein dilution and promotes vascular regeneration via the FGF21-adiponectin axis
Background Dietary preconditioning with caloric or protein restriction improves resilience to ischemic injury, but restrictive dietary regimens are difficult to implement in clinical practice. Carbohydrate loading is widely used in Enhanced Recovery After Surgery (ERAS) protocols to reduce perioperative metabolic stress, yet whether it can activate regenerative pathways associated with dietary protein restriction remains unknown. Methods Male C57BL6/J mice received a sucrose-rich drinking supplement for 5 days before hindlimb ischemia. Vascular repair, tissue injury and metabolic adaptation were assessed by histological, functional, molecular and metabolomic analyses. Genetic loss-of-function models and endothelial cell assays were used to investigate underlying mechanisms. Findings Short-term sucrose supplementation induced voluntary protein dilution despite increased caloric intake and reproduced key metabolic features of dietary protein restriction. This intervention activated hepatic nutrient-sensing pathways, increased circulating FGF21 and adiponectin levels, and improved glucose and lipid metabolism. Dietary preconditioning enhanced endothelial proliferation, angiogenesis and recovery following hindlimb ischemia. These benefits were abolished in Fgf21-deficient mice. Mechanistically, adiponectin promoted endothelial cell proliferation, migration and sprouting angiogenesis through PPARα-dependent metabolic adaptation. Interpretation Short-term carbohydrate supplementation is sufficient to engage a protein-restriction-like regenerative program without caloric restriction and enhances recovery from ischemic injury. These findings provide a mechanistic basis for carbohydrate-loading strategies and support dietary macronutrient manipulation as a practical approach to improve tissue resilience and vascular repair.
- 2 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessShort-term carbohydrate supplementation induces protein dilution and promotes vascular regeneration via the FGF21-adiponectin axis
Background Dietary preconditioning with caloric or protein restriction improves resilience to ischemic injury, but restrictive dietary regimens are difficult to implement in clinical practice. Carbohydrate loading is widely used in Enhanced Recovery After Surgery (ERAS) protocols to reduce perioperative metabolic stress, yet whether it can activate regenerative pathways associated with dietary protein restriction remains unknown. Methods Male C57BL6/J mice received a sucrose-rich drinking supplement for 5 days before hindlimb ischemia. Vascular repair, tissue injury and metabolic adaptation were assessed by histological, functional, molecular and metabolomic analyses. Genetic loss-of-function models and endothelial cell assays were used to investigate underlying mechanisms. Findings Short-term sucrose supplementation induced voluntary protein dilution despite increased caloric intake and reproduced key metabolic features of dietary protein restriction. This intervention activated hepatic nutrient-sensing pathways, increased circulating FGF21 and adiponectin levels, and improved glucose and lipid metabolism. Dietary preconditioning enhanced endothelial proliferation, angiogenesis and recovery following hindlimb ischemia. These benefits were abolished in Fgf21-deficient mice. Mechanistically, adiponectin promoted endothelial cell proliferation, migration and sprouting angiogenesis through PPARα-dependent metabolic adaptation. Interpretation Short-term carbohydrate supplementation is sufficient to engage a protein-restriction-like regenerative program without caloric restriction and enhances recovery from ischemic injury. These findings provide a mechanistic basis for carbohydrate-loading strategies and support dietary macronutrient manipulation as a practical approach to improve tissue resilience and vascular repair.
- Open Access
- 17 April 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (5) , e1779
Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study
Background.: Hydrogen sulfide (H2S) produced endogenously by the CTH gene-encoded cystathionine gamma-lyase protects from renal ischemia–reperfusion injury in preclinical models. Here, we hypothesized that CTH gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H2S serum levels influence kidney graft outcomes after transplantation. Methods.: We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H2S levels. The primary endpoint was graft loss during follow-up. Results.: CTH SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9–9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of CTH SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, P = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, P = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, P = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (P = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (P = 0.01). Finally, in patients with delayed graft function, serum H2S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate 2) (P = 0.05). Conclusions.: Graft outcome after kidney transplantation was associated with CTH genotype and, to some extent, H2S serum levels. Further research is needed to define the underlying protective mechanisms.
- 17 April 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (5) , e1779
Open AccessAssociation of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study
Background.: Hydrogen sulfide (H2S) produced endogenously by the CTH gene-encoded cystathionine gamma-lyase protects from renal ischemia–reperfusion injury in preclinical models. Here, we hypothesized that CTH gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H2S serum levels influence kidney graft outcomes after transplantation. Methods.: We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H2S levels. The primary endpoint was graft loss during follow-up. Results.: CTH SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9–9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of CTH SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, P = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, P = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, P = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (P = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (P = 0.01). Finally, in patients with delayed graft function, serum H2S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate 2) (P = 0.05). Conclusions.: Graft outcome after kidney transplantation was associated with CTH genotype and, to some extent, H2S serum levels. Further research is needed to define the underlying protective mechanisms.
- Open Access
- 26 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 93
Optimizing Photobiomodulation Radiometric and Spectral Parameters In Vitro to Enhance Angiogenesis and Mitochondrial Function
Photobiomodulation (PBM) therapy, a therapeutic approach utilizing low-level light, has garnered significant attention for its potential to modulate various biological processes. This study aimed at optimizing and investigating the effects of PBM on angiogenesis and mitochondrial metabolic activity. In vitro experiments using human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) were performed to assess PBM’s impacts on cell migration, proliferation, endogenous protoporphyrin IX production, mitochondrial membrane potential, Rhodamine 123 fluorescence lifetime, mitochondrial morphology, and oxygen consumption. Our findings demonstrated that the PBM approach significantly stimulates HUVECs and VSMCs, highlighting the importance of precise light dosimetry for optimal outcomes. Interestingly, our results indicate that in our conditions, the optimal radiometric and spectral parameters are similar for HUVECs and VSMCs for the different endpoints mentioned above. In conclusion, our study strongly suggests that PBM holds promise as a therapeutic intervention for conditions characterized by impaired angiogenesis, such as wound healing, ischemia, and cardiovascular disease. Further research is necessary to fully elucidate the underlying mechanisms and optimize the radiometric and spectral parameters for clinical applications.
- 26 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 93
Open AccessOptimizing Photobiomodulation Radiometric and Spectral Parameters In Vitro to Enhance Angiogenesis and Mitochondrial Function
Photobiomodulation (PBM) therapy, a therapeutic approach utilizing low-level light, has garnered significant attention for its potential to modulate various biological processes. This study aimed at optimizing and investigating the effects of PBM on angiogenesis and mitochondrial metabolic activity. In vitro experiments using human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) were performed to assess PBM’s impacts on cell migration, proliferation, endogenous protoporphyrin IX production, mitochondrial membrane potential, Rhodamine 123 fluorescence lifetime, mitochondrial morphology, and oxygen consumption. Our findings demonstrated that the PBM approach significantly stimulates HUVECs and VSMCs, highlighting the importance of precise light dosimetry for optimal outcomes. Interestingly, our results indicate that in our conditions, the optimal radiometric and spectral parameters are similar for HUVECs and VSMCs for the different endpoints mentioned above. In conclusion, our study strongly suggests that PBM holds promise as a therapeutic intervention for conditions characterized by impaired angiogenesis, such as wound healing, ischemia, and cardiovascular disease. Further research is necessary to fully elucidate the underlying mechanisms and optimize the radiometric and spectral parameters for clinical applications.
- Top Cited Papers
- 30 August 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (36) , 3538-3700
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
- 30 August 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (36) , 3538-3700
Top Cited Papers2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
- Open Access
- 28 September 2023
- Published by MDPI AG in Preprints.org
Unlocking Arteria Lusoria Challenges: Sternotomy's Role in a Single-Stage Aneurysm Repair and Artery Realignment.
This study presents a case report demonstrating an anomalous origin of the right subclavian artery from the aortic arch, accompanied by proximal dilation and a retro-esophageal course, characteristic of arteria lusoria and Kommerell's diverticulum. The research highlights the clinical significance of this anomaly and discusses its management strategies, emphasizing the importance of precise surgical intervention in addressing this condition.
- 28 September 2023
- Published by MDPI AG in Preprints.org
Open AccessUnlocking Arteria Lusoria Challenges: Sternotomy's Role in a Single-Stage Aneurysm Repair and Artery Realignment.
This study presents a case report demonstrating an anomalous origin of the right subclavian artery from the aortic arch, accompanied by proximal dilation and a retro-esophageal course, characteristic of arteria lusoria and Kommerell's diverticulum. The research highlights the clinical significance of this anomaly and discusses its management strategies, emphasizing the importance of precise surgical intervention in addressing this condition.
- Open Access
- 7 September 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (9) , 1731
Cystathionine Gamma Lyase Is Regulated by Flow and Controls Smooth Muscle Migration in Human Saphenous Vein
The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by three enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.
- 7 September 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (9) , 1731
Open AccessCystathionine Gamma Lyase Is Regulated by Flow and Controls Smooth Muscle Migration in Human Saphenous Vein
The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by three enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.
- Open Access
- 14 July 2023
- Published by MDPI AG in Preprints.org
Cystathionine gamma lyase is regulated by flow and controls smooth muscle migration in human saphenous vein
The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by 3 enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.
- 14 July 2023
- Published by MDPI AG in Preprints.org
Open AccessCystathionine gamma lyase is regulated by flow and controls smooth muscle migration in human saphenous vein
The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by 3 enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.
- Open Access
- 9 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (12) , 9955
Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease
Peripheral artery disease (PAD) affects more than 230 million people worldwide. PAD patients suffer from reduced quality of life and are at increased risk of vascular complications and all-cause mortality. Despite its prevalence, impact on quality of life and poor long-term clinical outcomes, PAD remains underdiagnosed and undertreated compared to myocardial infarction and stroke. PAD is due to a combination of macrovascular atherosclerosis and calcification, combined with microvascular rarefaction, leading to chronic peripheral ischemia. Novel therapies are needed to address the increasing incidence of PAD and its difficult long-term pharmacological and surgical management. The cysteine-derived gasotransmitter hydrogen sulfide (H2S) has interesting vasorelaxant, cytoprotective, antioxidant and anti-inflammatory properties. In this review, we describe the current understanding of PAD pathophysiology and the remarkable benefits of H2S against atherosclerosis, inflammation, vascular calcification, and other vasculo-protective effects.
- 9 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (12) , 9955
Open AccessClinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease
Peripheral artery disease (PAD) affects more than 230 million people worldwide. PAD patients suffer from reduced quality of life and are at increased risk of vascular complications and all-cause mortality. Despite its prevalence, impact on quality of life and poor long-term clinical outcomes, PAD remains underdiagnosed and undertreated compared to myocardial infarction and stroke. PAD is due to a combination of macrovascular atherosclerosis and calcification, combined with microvascular rarefaction, leading to chronic peripheral ischemia. Novel therapies are needed to address the increasing incidence of PAD and its difficult long-term pharmacological and surgical management. The cysteine-derived gasotransmitter hydrogen sulfide (H2S) has interesting vasorelaxant, cytoprotective, antioxidant and anti-inflammatory properties. In this review, we describe the current understanding of PAD pathophysiology and the remarkable benefits of H2S against atherosclerosis, inflammation, vascular calcification, and other vasculo-protective effects.
- 2 November 2022
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (3) , 423
Endovascular Repair of an Ascending Aortic Pseudoaneurysm
- 2 November 2022
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (3) , 423
Endovascular Repair of an Ascending Aortic Pseudoaneurysm